Skip to main content
. 2021 Nov 16;12(3):841–852. doi: 10.1016/j.jceh.2021.11.006

Table 6.

Univariate and Multivariable Logistic Regression Analysis of the Association of AFP Levels With Presence and Absence of ExtraHepatic Disease at Presentation.

Variable Extrahepatic metastasis
P value OR (95% CI) (Univariate) OR (95% CI, P value) (multivariate)
Absent n = 399 Present n = 109
Gender 0.5731
Male 347 (87%) 97 (89%) 1.21 (0.62–2.36) NA
Female 52 (13%) 12 (11%) Ref
Age 0.0031
≤40 49 (12.3%) 26 (23.8%) 2.24 (1.31–3.81) 1.87 (1.09–3.22,P value = 0.023)
>40 350 (87.7%) 83 (76.2%) Ref
Etiology 0.2781 NA
HBHC 237 (59.4%) 71 (65.1%) 1.28 (0.82–1.99)
NBNC 162 (40.6%) 38 (34.9%) Ref
AFP (ng/ml)
(mean ± SD)
55420.64
±
203280.01
116718.39
+
295452.47
0.0012
AFP (ng/ml) 0.0411
<10 79 (19.8%) 13 (11.9%) Ref
10–400 119 (29.8%) 27 (24.8%) 1.38 (0.67–2.83, P = 0.382) 1.26 (0.60–2.64,P = 0.536)
>400 201 (50.4%) 69 (63.3%) 2.09 (1.09–3.98, P = 0.026) 1.69 (0.87–3.29,P = 0.119)
AFP (ng/ml) 0.171
≤400 198 (49.6%) 40 (36.7%) Ref
>400 201 (50.4%) 69 (63.3%) 1.69 (1.09–2.63)
MTD (cm) <0.0011
≤5 84 (21.1%) 4 (3.7%) Ref
>5 315 (78.9%) 105 (96.3%) 7.00 (2.51–19.55) 5.95 (2.11–16.74,P value = 0.001)

All values: Mean ± Standard Deviation as continuous; Frequencies and percentage (%) as categorical.

1. Chi-square test 2. Mann–Whitney U test.

MTD (Maximum tumor diameter); AFP (Alfa-fetoprotein); HBHC (Hepatitis B and hepatitis C); NBNC (Nonhepatitis B and nonhepatitis C).